Collplant Biotechnologies Ltd

詳細情報 Collplant Biotechnologies Ltd 企業名

CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

企業情報

企業コードCLGN

会社名Collplant Biotechnologies Ltd

上場日Sep 01, 1993

最高経営責任者「CEO」Mr. Eran Rotem, CPA

従業員数57

証券種類Ordinary Share

決算期末Sep 01

本社所在地4 Oppenheimer Street

都市REHOVOT

証券取引所NASDAQ Global Market Consolidated

国Israel

郵便番号7670104

電話番号972732325600

ウェブサイトhttps://www.collplant.com

企業コードCLGN

上場日Sep 01, 1993

最高経営責任者「CEO」Mr. Eran Rotem, CPA

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Yehiel Tal

Chief Executive Officer

31.14K

--

Dr. Philippe David Bensimon

Vice President - Regulatory Affairs and Quality Assurance

2.00K

--

Dr. Nadav Orr

Vice President - Research & Development

--

Dr. Elan Penn, Ph.D.

Independent Director

--

Dr. Roger J. Pomerantz, M.D.

Independent Chairman of the Board

--

Dr. Oded Shoseyov, Ph.D.

Founder, Chief Scientist

--

Dr. Gili Hart

Independent Director

--

Mr. Joseph Zarzewsky

Independent Director

--

Mr. Eran Rotem, CPA

Deputy Chief Executive Officer, Chief Financial Officer

--

Dr. Abraham (Avri) Havron, Ph.D.

Independent Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Yehiel Tal

Chief Executive Officer

31.14K

--

Dr. Philippe David Bensimon

Vice President - Regulatory Affairs and Quality Assurance

2.00K

--

Dr. Nadav Orr

Vice President - Research & Development

--

Dr. Elan Penn, Ph.D.

Independent Director

--

Dr. Roger J. Pomerantz, M.D.

Independent Chairman of the Board

--

Dr. Oded Shoseyov, Ph.D.

Founder, Chief Scientist

--

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2024

FY2024Q2

FY2023

FY2023Q2

FY2022

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Revenues from the sales of goods

515.00K

0.00%

地域別USD

会社名

収益

比率

United States

484.00K

93.98%

Israel

31.00K

6.02%

Europe

0.00

0.00%

Canada

0.00

0.00%

事業別

地域別

事業別USD

会社名

収益

比率

Revenues from the sales of goods

515.00K

0.00%

株主

更新時刻: Sat, May 17

株主統計

種類

株主統計

比率

Sagy (Ami)

15.28%

Loewenbaum (George Walter)

8.97%

St. Denis J. Villere & Company, LLC

4.30%

Pinnacle Associates Ltd.

3.85%

Evans (Hugh M)

2.97%

Other

64.63%

株主統計

比率

Sagy (Ami)

15.28%

Loewenbaum (George Walter)

8.97%

St. Denis J. Villere & Company, LLC

4.30%

Pinnacle Associates Ltd.

3.85%

Evans (Hugh M)

2.97%

Other

64.63%

種類

株主統計

比率

Individual Investor

29.91%

Investment Advisor

7.11%

Investment Advisor/Hedge Fund

4.77%

Hedge Fund

1.06%

Family Office

0.13%

Research Firm

0.11%

Other

56.90%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

40

5.46M

42.96%

+129.16K

2025Q1

43

5.89M

47.00%

-12.15K

2024Q4

45

6.34M

55.34%

-153.24K

2024Q3

47

6.23M

54.37%

+33.99K

2024Q2

47

6.08M

53.11%

-244.01K

2024Q1

47

6.01M

52.48%

-307.66K

2023Q4

51

6.09M

53.32%

-149.24K

2023Q3

56

6.34M

55.87%

-109.84K

2023Q2

58

6.40M

56.58%

+145.86K

2023Q1

60

5.97M

52.82%

-340.05K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Sagy (Ami)

1.94M

15.28%

--

Mar 15, 2025

Loewenbaum (George Walter)

1.14M

8.97%

+86.46K

+8.20%

Dec 31, 2024

St. Denis J. Villere & Company, LLC

483.87K

3.81%

--

Mar 31, 2025

Pinnacle Associates Ltd.

489.19K

3.85%

-500.00

-0.10%

Mar 31, 2025

Evans (Hugh M)

377.43K

2.97%

-1.00

-0.00%

Mar 15, 2025

Roumell Asset Management, L.L.C.

276.43K

2.17%

-38.86K

-12.32%

Jun 30, 2024

Loewenbaum (Lilian Shaw)

275.74K

2.17%

+70.09K

+34.08%

Dec 31, 2024

AMH Equity, Ltd.

125.00K

0.98%

+8.50K

+7.30%

Mar 31, 2025

Brown Advisory

111.20K

0.87%

-8.27K

-6.92%

Mar 31, 2025

Benjamin F. Edwards & Company, Inc.

39.76K

0.31%

-10.69K

-21.19%

Jun 30, 2024

詳細を見る

2.260USD

Collplant Biotechnologies Ltd

2.260

概要

企業名

金融